Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...
Securing FDA clearance or approval is a major accomplishment for medical device and pharmaceutical companies, but it’s not ...
stockhead on MSN3d
Biocurious: EBR Systems is on a ‘glide path’ to FDA approval for its novel heart deviceEBR Systems is super confident the US medical gatekeeper will approve Wise, the world's first wireless pacemaker device.
However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...
Trump's pick for HHS secretary who endured confirmation hearings last week—has repeatedly criticized industry ties to the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback